These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7615652)
21. c-Myc induces the expression and activity of ornithine decarboxylase. Wagner AJ; Meyers C; Laimins LA; Hay N Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793 [TBL] [Abstract][Full Text] [Related]
22. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Packham G; Cleveland JL Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616 [TBL] [Abstract][Full Text] [Related]
23. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Kuo ML; Chou YW; Chau YP; Huang TS Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217 [TBL] [Abstract][Full Text] [Related]
24. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells. Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677 [TBL] [Abstract][Full Text] [Related]
25. Ornithine decarboxylase regulates the activity and localization of rhoA via polyamination. Mäkitie LT; Kanerva K; Andersson LC Exp Cell Res; 2009 Apr; 315(6):1008-14. PubMed ID: 19331812 [TBL] [Abstract][Full Text] [Related]
26. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients. Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102 [TBL] [Abstract][Full Text] [Related]
27. Scanning microphotometry image analysis of Ha-ras-transformed human breast epithelial cells. Mello ML; Lin TY; Russo J Anal Cell Pathol; 1994 Dec; 7(4):301-19. PubMed ID: 7696155 [TBL] [Abstract][Full Text] [Related]
28. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Shantz LM; Pegg AE Cancer Res; 1994 May; 54(9):2313-6. PubMed ID: 8162572 [TBL] [Abstract][Full Text] [Related]
30. DNA methylation affecting the transforming activity of the human Ha-ras oncogene. Borrello MG; Pierotti MA; Bongarzone I; Donghi R; Mondellini P; Della Porta G Cancer Res; 1987 Jan; 47(1):75-9. PubMed ID: 2431768 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Lan L; Trempus C; Gilmour SK Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762 [TBL] [Abstract][Full Text] [Related]
32. Ornithine decarboxylase: an indicator for growth of NIH 3T3 fibroblasts and their c-Ha-ras transformants. Shayovits A; Bachrach U Biochim Biophys Acta; 1995 Jun; 1267(2-3):107-14. PubMed ID: 7612662 [TBL] [Abstract][Full Text] [Related]
33. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1. Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468 [TBL] [Abstract][Full Text] [Related]
34. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras. Takahashi N; De Luca LM; Breitman TR Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273 [TBL] [Abstract][Full Text] [Related]
35. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. Xin H; Geng Y; Pramanik R; Choubey D J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788 [TBL] [Abstract][Full Text] [Related]
36. Cell-cycle-dependent expression of human ornithine decarboxylase. Kaczmarek L; Calabretta B; Ferrari S; de Riel JK J Cell Physiol; 1987 Sep; 132(3):545-51. PubMed ID: 3308908 [TBL] [Abstract][Full Text] [Related]
37. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells. Reynaud C; Gleyzal C; Jourdan-Le Saux C; Sommer P Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1237-47. PubMed ID: 10643973 [TBL] [Abstract][Full Text] [Related]